<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.immunetolerance.org" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Immune Tolerance Network</title>
 <link>http://www.immunetolerance.org/public</link>
 <description>Latest News</description>
 <language>en</language>
<item>
 <title>Celebrate Ten Years of Tolerance!</title>
 <link>http://www.immunetolerance.org/news/2010/07/celebrate-ten-years-tolerance</link>
 <description>&lt;p&gt;
&lt;span style=&quot;font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; color: black; font-size: 10pt&quot;&gt;This year marks the Immune Tolerance Network&amp;#39;s 10th anniversary! To celebrate, the ITN invites you to attend a one day symposium - &amp;quot;&lt;strong&gt;&lt;span style=&quot;font-family: &#039;Arial&#039;,&#039;sans-serif&#039;&quot;&gt;Ten Years of Tolerance&lt;/span&gt;&lt;/strong&gt;&amp;quot; on &lt;strong&gt;&lt;span style=&quot;font-family: &#039;Arial&#039;,&#039;sans-serif&#039;&quot;&gt;November 1, 2010&lt;/span&gt;&lt;/strong&gt; at the National Institutes of Health in Bethesda, MD.&lt;/span&gt; 
&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://www.immunetolerance.org/news/2010/07/celebrate-ten-years-tolerance&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.immunetolerance.org/category/news-type/general-news">General-News</category>
 <pubDate>Mon, 19 Jul 2010 12:54:59 -0700</pubDate>
 <dc:creator>ndarbous</dc:creator>
 <guid isPermaLink="false">641 at http://www.immunetolerance.org</guid>
</item>
<item>
 <title>Possible first new treatment for ANCA-associated vasculitis in 40 years</title>
 <link>http://www.immunetolerance.org/news/2010/07/possible-first-new-treatment-anca-associated-vasculitis-40-years</link>
 <description>&lt;p&gt;
Results of an Immune Tolerance Network clinical trial may provide doctors with another weapon in the treatment of ANCA-associated vasculitis, which has seen no new approved treatments in 40 years. The study, published in the New England Journal of Medicine, showed that the drug rituximab provides the same treatment benefits as the existing standard of care, and appears to offer additional benefits to those suffering relapses. 
&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://www.immunetolerance.org/news/2010/07/possible-first-new-treatment-anca-associated-vasculitis-40-years&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.immunetolerance.org/category/news-type/general-news">General-News</category>
 <pubDate>Thu, 15 Jul 2010 14:09:09 -0700</pubDate>
 <dc:creator>itn_admin</dc:creator>
 <guid isPermaLink="false">639 at http://www.immunetolerance.org</guid>
</item>
<item>
 <title>A Signature of Transplant Tolerance?</title>
 <link>http://www.immunetolerance.org/news/2010/06/signature-transplant-tolerance</link>
 <description>&lt;img src=&quot;/sites/files/rherck.png&quot; hspace=&quot;5&quot; vspace=&quot;5&quot; width=&quot;180&quot; height=&quot;134&quot; align=&quot;right&quot; /&gt;On December 23rd, 1953 at the Peter Bent Brigham Hospital in Boston, a team of surgeons carefully removed a healthy kidney from a 23-year-old man named Ronald Herrick. Working quickly, they wrapped the donor organ in a cold, wet towel, placed it in a stainless steel dish, and carried it into a different operating room. There, Ronald’s identical twin Richard lay dying of chronic nephritis. His brother’s healthy kidney was his only chance at survival.&lt;br /&gt;
&lt;p&gt;&lt;a href=&quot;http://www.immunetolerance.org/news/2010/06/signature-transplant-tolerance&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.immunetolerance.org/category/news-type/features">Features</category>
 <pubDate>Wed, 16 Jun 2010 21:17:18 -0700</pubDate>
 <dc:creator>itn_admin</dc:creator>
 <guid isPermaLink="false">637 at http://www.immunetolerance.org</guid>
</item>
</channel>
</rss>
